Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

Biotechnology

Health Care

Personal Health

Pharmaceutical

Aprea

Aprea's headquarters in Stockholm, Sweden

Oren Gilad

Nadeem Mirza

John P. Hamill

Ze’ev Weiss

John B. Henneman

Michael Grissinger

Rifat Pamukcu

Richard Peters

Bernd R. Seizinger

Marc Duey

Gabriela Gruia

John B. Henneman Iii

Chritian S. Schade

Jean-Pierre Bizzari

The Advisory Team at Aprea leverages extensive expertise in translational medicine, business strategy, and medical insights to guide the development of innovative anticancer therapies targeting the p53 protein. They provide critical guidance on clinical strategy, navigate regulatory landscapes, and foster partnerships to enhance the discovery pipeline and optimize the commercialization of novel compounds.

Advisory Team

Aprea

Org chart

Board & advisors

Teams

Advisory Team

Offices

Similar companies